POSA370 Healthcare Resource Use By European Patients Enrolled in RA-be-Real: A Multinational, Prospective, Observational Study of the Effectiveness, Healthcare Resource Utilization and Costs in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic or Biologic Disease Modifying Therapies
Saved in:
| Title: | POSA370 Healthcare Resource Use By European Patients Enrolled in RA-be-Real: A Multinational, Prospective, Observational Study of the Effectiveness, Healthcare Resource Utilization and Costs in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic or Biologic Disease Modifying Therapies |
|---|---|
| Authors: | Alten, R1 (AUTHOR), Burmester, G2 (AUTHOR), Matucci-Cerinic, M3 (AUTHOR), Salmon, JH4 (AUTHOR), Zaremba-Pechmann, L5 (AUTHOR), Fakhouri, W5 (AUTHOR), de La Torre, I5 (AUTHOR), Herrera, M5 (AUTHOR), Holzkämper, T5 (AUTHOR), Fautrel, B6 (AUTHOR) |
| Source: | Value in Health. 2022 Supplement, Vol. 25 Issue 1, pS221-S221. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
